Diamyd Medical (Germany) Analysis

Diamyd Stock Analysis Notes

About 35.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.11. Diamyd Medical AB had not issued any dividends in recent years. Diamyd Medical AB , a diabetes company, engages in the development of combination therapies for the treatment of autoimmune diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB in April 2013. DIAMYD MEDICAL operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6 people. To learn more about Diamyd Medical AB call Ulf MBA at 46 86 61 00 26 or check out https://www.diamyd.com.

Diamyd Medical AB Investment Alerts

Diamyd Medical Thematic Classifications

Diamyd Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 99.6 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Diamyd Medical's market, we take the total number of its shares issued and multiply it by Diamyd Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 24th of March, Diamyd Medical shows the Mean Deviation of 2.79, standard deviation of 5.35, and Coefficient Of Variation of (702.01). Diamyd Medical AB technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Diamyd Medical AB information ratio, potential upside, and the relationship between the standard deviation and maximum drawdown to decide if Diamyd Medical AB is priced favorably, providing market reflects its regular price of 0.73 per share.

Diamyd Medical AB Price Movement Analysis

Diamyd Medical Outstanding Bonds

Diamyd Medical Predictive Daily Indicators

Diamyd Medical Forecast Models

Diamyd Medical's time-series forecasting models are one of many Diamyd Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Diamyd Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Diamyd Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Diamyd shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Diamyd Medical. By using and applying Diamyd Stock analysis, traders can create a robust methodology for identifying Diamyd entry and exit points for their positions.

When running Diamyd Medical's price analysis, check to measure Diamyd Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diamyd Medical is operating at the current time. Most of Diamyd Medical's value examination focuses on studying past and present price action to predict the probability of Diamyd Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diamyd Medical's price. Additionally, you may evaluate how the addition of Diamyd Medical to your portfolios can decrease your overall portfolio volatility.